Posted by Michael Wonder on 15 Jul 2021
Pharma companies fined after 10,000% price rise for life saving drug
15 July 2021 - UK watchdog imposes £260 million in penalties for increases in costs of hydrocortisone tablets.
The Competition and Markets Authority said on Thursday that Auden Mckenzie and Actavis UK, now known as Accord UK, had “charged the NHS excessively high prices for hydrocortisone tablets for almost a decade”.
